Preoperative Cisplatin vs Paclitaxel in Triple-Negative Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
TBCRC 030: A Phase II Study of Preoperative Cisplatin vs. Paclitaxel in Triple-Negative Breast Cancer: Evaluating the Homologous Recombination Deficiency (HRD) Biomarker
Ann. Oncol 2020 Aug 13;[EPub Ahead of Print], EL Mayer, V Abramson, R Jankowitz, C Falkson, PK Marcom, T Traina, L Carey, M Rimawi, J Specht, K Miller, V Stearns, N Tung, C Perou, AL Richardson, K Componeschi, L Trippa, Z Tan-Wasielewski, K Timms, I Krop, AC Wolff, EP WinerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.